Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$26,455,829
-$264,409 QoQ
Shares Held
22,057
-24.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#773
of 4,627 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds $313,691,256 across 2 Drug Manufacturers - General names. LLY ranks #2 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,514,795 | $287,235,427 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
22,057 | $26,455,829 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,455,829 | 22,057 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $26,720,238 | 29,051 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $34,406,958 | 32,016 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $11,731,125 | 15,375 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,032,593 | 20,567 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $37,844,848 | 45,822 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $35,014,060 | 45,355 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $24,063,902 | 27,162 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,759,153 | 1,943 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,540,360 | 1,980 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||